ScholarIQanswers from OpenAlex

Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products

PaperCitations, authors & open-access status

Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products have?

ScholarIQcitation count

Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products has 26 citations in the OpenAlex counts ScholarIQ stores.

When was Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products published?

ScholarIQyear

Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products has 2015 year in the ScholarIQ index.

What is the open-access status of Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products?

ScholarIQoa status

Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products has closed oa status in the ScholarIQ index.

What is the DOI of Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products?

ScholarIQdoi

The DOI for Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products is on the source record.

What is the PMID of Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products?

ScholarIQpmid

The PMID for Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products is on the source record.

What is the OpenAlex record for Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products?

ScholarIQopenalex

The OpenAlex for Wound closure in patients with DFU: a cost-effectiveness analysis of two cellular/tissue-derived products is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial